About Focus on Diabetes

Closeup view of person's eye

Eye Health

About Focus on Diabetes

ADA logo with Focus On Diabetes logo

Focus on Diabetes is a multi-year initiative that brings together the American Diabetes Association and Visionary Partners from leading organizations in vision care to increase awareness about diabetes and eye health. This initiative provides easy steps and valuable information and experiences to prevent diabetes-related eye disease and preserve eyesight.

Many people with diabetes-related eye disease are at risk for vision complications. The most common diabetes-related eye conditions are diabetic retinopathy (DR) diabetic macular edema, (DME) cataracts, glaucoma and vision loss; the good news is that it is preventable with early detection, timely treatment, and appropriate follow-up care.

The economic burden of diabetes on the United States healthcare system is $139 billion for vision-related disorders alone. For those living with diabetes, an annual eye exam with an eye care professional can help prevent or delay disease and vision loss caused by diabetes. Focus on Diabetes responds to the personal and economic costs of diabetes and eye disease by raising awareness and suggesting actions for those at risk for diabetes-related eye disease. FOD provides support and education to those affected by diabetes-related eye disease and educates health care professionals about diabetes-related eye disease and how to prevent it.

There are currently over 37 million American adults living with diabetes, and around 96 million Americans living with prediabetes. However, nearly 81% don’t know they have prediabetes.[i]

Download the 2020 Impact Report

Download the 2021 Impact Report

American Diabetes Association®, VSP® Vision Care, and Regeneron Pharmaceuticals, Inc. are collaborating on a public health initiative to save sight in those living with diabetes. Focus on Diabetes™ a multi-year campaign will raise awareness of the critical role eye exams can play in early detection and prevention of diabetes-related eye disease and on an often overlooked but costly and devastating complication of diabetes: vision loss.

VSP® Vision Care and Regeneron Pharmaceuticals, are dedicated to helping people maintain their vision, including those with diabetes. This partnership will help spread awareness to those living with diabetic eye disease, their caregivers and health care providers, which will help reduce health care costs associated with diabetes-related eye disease and vision loss.[ii]

[i] Centers for Disease Control and Prevention. Diabetes Fast Facts, available at https://www.cdc.gov/diabetes/basics/quick-facts.html. Accessed May 10, 2022.
[ii] Klunk, E. MedCity News. How to curb the high cost of diabetic eye disease, available at https://medcitynews.com/2020/01/how-to-curb-the-high-cost-of-diabetic-eye-disease/. Accessed May 10, 2022.